Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01680575|
Recruitment Status : Unknown
Verified May 2017 by Jeong-Yeol Park, Asan Medical Center.
Recruitment status was: Recruiting
First Posted : September 7, 2012
Last Update Posted : May 31, 2017
|Condition or disease|
|Epithelial Ovarian Cancer|
|Study Type :||Observational|
|Estimated Enrollment :||750 participants|
|Official Title:||Development of a Risk Model Predicting Chemotherapy-induced Grade 3-4 Neutropenia by Paclitaxel/Carboplatin in Epithelial Ovarian Cancer: Prospective Observational Study for Model Development and Retrospective Study for Validation of Developed Model|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||May 2018|
|Estimated Study Completion Date :||May 2018|
This cohort is a prospective cohort to develop a risk prediction model. This cohort include patients who underwent staging operation or debulking operation for epithelial ovarian cancer and are planned to receive ajuvant chemotherapy with paclitaxel/carboplatin up to 6 cycles.
This is a retrospective cohort for validation of a risk prediction model developed using training cohort.
This is consisted with 600 patients with epithelial ovarian cancer who received adjuvant chemotherapy with paclitaxel/carboplatin after staging operation or debulking operation.
- Risk prediction model for grade 3-4 chemotherapy induced neutropenia [ Time Frame: 1 year ]
- The association between mannose-binding lectin 2 gene SNP and neutropenia [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01680575
|Contact: Jeong-Yeol Park, M.D., Ph.D.||firstname.lastname@example.org|
|Korea, Republic of|
|Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center||Recruiting|
|Seoul, Korea, Republic of, 138-736|
|Contact: Jeong-Yeol Park, M.D., Ph.D.|
|Principal Investigator:||Jeong-Yeol Park, M.D., Ph.D.||Asan Medical Center|